[1]
T. Tunthanathip and T. Bejrananda, “PD-1/PD-L1 Immune Checkpoint Inhibitors after Platinum-based Chemotherapy in Metastatic or Locally Advanced Urothelial Bladder Carcinoma: A Systematic Review and Meta-analysis: PD-1/PD-L1 Immune Checkpoint Inhibitors in Locally Advanced or Metastatic Urothelial Carcinoma”, PSU Med J, vol. 1, no. 3, pp. 99–107, Sep. 2021.